Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use WILATE safely and effectively. See full prescribing information for WILATE. WILATE (von Willebrand Factor/Coagulation Factor VIII Complex (Human)) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-other
WILATE is indicated in adult and pediatric patients with von Willebrand disease (VWD) for: On-demand treatment and control of bleeding episodes Perioperative management of bleeding Routine prophylaxis to reduce the frequency of bleeding episodes WILATE is indicated in adult and pediatric patients 12 years of age and older with hemophilia A for: On-demand treatment and control of bleeding episodes Routine prophylaxis to reduce the frequency of bleeding episodes
- generic_name
- von willebrand factor/coagulation factor viii complex (human)
- product_names
- von Willebrand Factor/Coagulation Factor VIII Complex (Human)
- ndc
- 68982-182, 68982-182-02, 68982-182-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en